Enterprise Value
-44.32M
Cash
103.5M
Avg Qtr Burn
-20.34M
Short % of Float
2.04%
Insider Ownership
16.48%
Institutional Own.
66.60%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ALG-000184 (Capsid Assembly modulator) Details Chronic hepatitis B | Phase 1 Data readout | |
ALG-125755 Details Chronic hepatitis B, Liver disease | Phase 1 Data readout | |
ALG-055009 (THR-β Agonist) Details Non-alcoholic steatohepatitis | Phase 1 Update | |
ALG-010133 (S-antigen Transport-inhibiting Oligonucleotide Polymer) Details Chronic hepatitis B | Failed Discontinued |